Literature DB >> 7928674

Crocacin, a new electron transport inhibitor from Chondromyces crocatus (myxobacteria). Production, isolation, physico-chemical and biological properties.

B Kunze1, R Jansen, G Höfle, H Reichenbach.   

Abstract

Crocacin was isolated from the biomass of the myxobacterium Chondromyces crocatus, strain Cm c3. It inhibited the growth of a few Gram-positive bacteria and a wide spectrum of yeasts and molds. In beef heart submitochondrial particles, crocacin blocked the electron transport within the bc1-segment (complex III) and caused a red shift in the reduced spectrum of cytochrome b with a maximum at 569 nm.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7928674     DOI: 10.7164/antibiotics.47.881

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  13 in total

1.  Enantioselective synthesis of (+)-crocacin C. An example of a highly challenging mismatched double asymmetric δ-stannylcrotylboration reaction.

Authors:  Ming Chen; William R Roush
Journal:  Org Lett       Date:  2012-03-12       Impact factor: 6.005

2.  Molecular and functional characterization of myxobacteria isolated from soil in India.

Authors:  Shiv Kumar; Arun Kumar Yadav; Priyanka Chambel; Ramandeep Kaur
Journal:  3 Biotech       Date:  2017-05-31       Impact factor: 2.406

3.  Synthesis and biological evaluation of (-)-kunstleramide and its derivatives.

Authors:  R Venkateshwarlu; B Chinnababu; U Ramulu; K Purushotham Reddy; M Damoder Reddy; P Sowjanya; P Venkateswara Rao; S Aravind
Journal:  Medchemcomm       Date:  2016-12-09       Impact factor: 3.597

4.  Catalytic Reactions and Energy Conservation in the Cytochrome bc1 and b6f Complexes of Energy-Transducing Membranes.

Authors:  Marcin Sarewicz; Sebastian Pintscher; Rafał Pietras; Arkadiusz Borek; Łukasz Bujnowicz; Guy Hanke; William A Cramer; Giovanni Finazzi; Artur Osyczka
Journal:  Chem Rev       Date:  2021-01-19       Impact factor: 60.622

5.  Molecular evidence for association between the sphingobacterium-like organism "Candidatus comitans" and the myxobacterium Chondromyces crocatus.

Authors:  C A Jacobi; B Assmus; H Reichenbach; E Stackebrandt
Journal:  Appl Environ Microbiol       Date:  1997-02       Impact factor: 4.792

6.  Iterative Cross-Couplng with MIDA Boronates: Towards a General Platform for Small Molecule Synthesis.

Authors:  Eric P Gillis; Martin D Burke
Journal:  Aldrichimica Acta       Date:  2009       Impact factor: 3.667

7.  The role of molecular modeling in the design of analogues of the fungicidal natural products crocacins A and D.

Authors:  Patrick J Crowley; Edward A Berry; Thomas Cromartie; Fevzi Daldal; Christopher R A Godfrey; Dong-Woo Lee; Janet E Phillips; Anne Taylor; Russell Viner
Journal:  Bioorg Med Chem       Date:  2008-10-17       Impact factor: 3.641

Review 8.  Structural basis of resistance to anti-cytochrome bc₁ complex inhibitors: implication for drug improvement.

Authors:  Lothar Esser; Chang-An Yu; Di Xia
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

9.  Genome Analysis of the Fruiting Body-Forming Myxobacterium Chondromyces crocatus Reveals High Potential for Natural Product Biosynthesis.

Authors:  Nestor Zaburannyi; Boyke Bunk; Josef Maier; Jörg Overmann; Rolf Müller
Journal:  Appl Environ Microbiol       Date:  2016-01-15       Impact factor: 4.792

10.  Multistep synthesis of complex boronic acids from simple MIDA boronates.

Authors:  Eric P Gillis; Martin D Burke
Journal:  J Am Chem Soc       Date:  2008-10-07       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.